Coastal Anesthesiology, 100 Whetstone Place #310, St Augustine, FL 32086, USA.
Br J Anaesth. 2014 May;112(5):906-11. doi: 10.1093/bja/aet551. Epub 2014 Feb 18.
Patients undergoing bariatric surgery are at high risk of postoperative nausea and vomiting (PONV). Despite triple PONV prophylaxis, up to 42.7% of patients require antiemetic rescue medication (AERM).
This prospective, randomized study was conducted from November 2011 to October 2012. In the Classic group (n=59), patients underwent general anaesthesia with volatile anaesthetics and opioids. In the Total i.v. anaesthesia (TIVA) group (n=60), patients underwent opioid-free TIVA with propofol, ketamine, and dexmedetomidine. The severity of PONV was assessed using a Likert scale (none, mild, moderate, and severe).
Patients in both groups had similar clinical characteristics, surgical procedure, and PONV risk scores and required similar amounts of postoperative opioid. In the Classic group, 22 patients (37.3%) reported PONV compared with 12 patients (20.0%) in the TIVA group [P=0.04; risk 1.27 (1.01-1.61)]. The absolute risk reduction was 17.3% (number-needed-to-treat=6). The severity of nausea was statistically different in both groups (P=0.02). The severity of PONV was significantly worse in the Classic group. There was no difference either in the number of patients requiring AERM in the postoperative period or in the number of AERM doses required.
This prospective randomized study demonstrates that opioid-free TIVA is associated with a large reduction in relative risk of PONV compared with balanced anaesthesia. Clinical trial registration NCT 01449708 (ClinicalTrials.gov).
接受减重手术的患者术后恶心呕吐(PONV)的风险很高。尽管进行了三重 PONV 预防,但仍有多达 42.7%的患者需要使用止吐急救药物(AERM)。
这是一项前瞻性、随机研究,于 2011 年 11 月至 2012 年 10 月进行。在 Classic 组(n=59)中,患者接受含挥发性麻醉剂和阿片类药物的全身麻醉。在 Total i.v. anaesthesia(TIVA)组(n=60)中,患者接受无阿片类药物的 TIVA,使用丙泊酚、氯胺酮和右美托咪定。PONV 的严重程度使用李克特量表(无、轻度、中度和重度)进行评估。
两组患者的临床特征、手术程序和 PONV 风险评分相似,并且需要的术后阿片类药物量相似。在 Classic 组中,22 名患者(37.3%)报告有 PONV,而 TIVA 组中只有 12 名患者(20.0%)[P=0.04;风险 1.27(1.01-1.61)]。绝对风险降低 17.3%(需要治疗的人数=6)。两组患者的恶心严重程度存在统计学差异(P=0.02)。Classic 组的 PONV 严重程度明显更差。术后需要 AERM 的患者人数或所需 AERM 剂量在两组之间没有差异。
这项前瞻性随机研究表明,与平衡麻醉相比,无阿片类药物的 TIVA 可显著降低 PONV 的相对风险。临床试验注册 NCT 01449708(ClinicalTrials.gov)。